Arecor Therapeutics plc announced unaudited consolidated earnings results for the six months ended 30 June 2021. For the period, the company reported Revenue of £460,021 against £817,043 a year ago. Operating loss was £2,956,336 against £1,341,284 a year ago. Loss for the period was £3,105,547 against £1,046,829 a year ago. Basic and diluted loss per share £0.17 against £0.06 a year ago.